Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Total Liabilities (2016 - 2025)

Bio Key International's Total Liabilities history spans 16 years, with the latest figure at $4.1 million for Q3 2025.

  • For Q3 2025, Total Liabilities fell 35.08% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, down 35.08%, while the annual FY2024 figure was $4.8 million, 40.25% up from the prior year.
  • Total Liabilities for Q3 2025 was $4.1 million at Bio Key International, up from $3.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $6.7 million in Q2 2023 and bottomed at $1.9 million in Q1 2021.
  • The 5-year median for Total Liabilities is $4.0 million (2022), against an average of $4.3 million.
  • The largest annual shift saw Total Liabilities plummeted 57.99% in 2021 before it surged 180.59% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $2.2 million in 2021, then soared by 180.59% to $6.0 million in 2022, then tumbled by 42.85% to $3.5 million in 2023, then soared by 40.25% to $4.8 million in 2024, then decreased by 16.01% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Total Liabilities are $4.1 million (Q3 2025), $3.7 million (Q2 2025), and $3.7 million (Q1 2025).